IN-DATE
11500A-23mm: Edwards Inspiris Resilia Aortic Valve 23mm
Sign in to add this product to your favorites!
| Price: | $10,999.00 $9,899.10 per box of 1 |
|---|---|
| In Stock: | 0 box of 1 |
| Expiration: | In-Date |
We currently do not have this item in stock, but we can email you as soon as it is available.
Related Items
QUICK VIEW
| 11500A-27mm - Size: 27.00mm $10,999.00 per box of 1 Edwards Inspiris Resilia Aortic Valve 27mm Exp: 09-2027 Units in stock: 1 box of 1 | Order Qty |
|
QUICK VIEW
| 11500A-29mm - Size: 29.00mm $10,999.00 $9,899.10 per box of 1 Edwards Inspiris Resilia Aortic Valve 29mm Exp: 12-2029 Units in stock: 1 box of 1 | Order Qty |
Additional Details
Edwards Lifesciences Inspiris Resilia Aortic Valve
The INSPIRIS RESILIA aortic valve is built upon the Carpentier-Edwards PERIMOUNT valve which has been widely used in the US for over 25 years. The INSPIRIS valve is a resilient heart valve made of RESILIA tissue. It is a bovine (cow) heart tissue that has been preserved with a special Edwards technology to reduce calcium build-up on the valve tissue and allow the valve to be stored dry. Traditional tissue valves are treated with, and many are stored in, glutaraldehyde, a chemical that attracts calcium. Calcium build-up on the valve tissue can cause the valve not to open and close properly, requiring re-operation to replace it. The special technology used in the RESILIA tissue on the INSPIRIS valve blocks the calcium from depositing on the tissue. It also prevents further exposure to glutaraldehyde, by allowing the valve to be stored dry.
AccessGUDID Info
- FDA Product Code: LWR
- FDA Product Code Name: Heart-Valve, Non-Allograft Tissue
- GMDN Term Code: 60242
- GMDN Term Name: Aortic open-surgery heart valve bioprosthesis
- GMDN Term Description: A xenograft (e.g., porcine or bovine heart valve) intended to be implanted in a patient during open heart surgery to repair or replace a dysfunctional aortic heart valve. It is processed to render the tissue in the valve non-viable; it may be tissue only, or tissue attached to a metal or synthetic polymer framework. The device is typically used to treat acquired or congenital valvular disease.
Manufacturer
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives. Shop Clot Management, Pressure Monitoring, TD Catheters and more from Synergy Surgical's collection of Edwards products.
